Dr. Lindsay Rosenwald’s Remarkable Success with Cougar Biotechnology 0
Through his enthusiastic approach in biotechnology research and analysis, Dr. Lindsay Rosenwald has been known as one of the most sought-after experts in this field of specialization. Dr. Rosenwald has been in the medical and investment field, at the same time, for almost two decades already. During this period, he has successfully built numerous medical-related firms that are centered on making significant research and studies to come up with innovative solutions on mankind’s common health problems.
Among the many companies he has established, Dr. Lindsay Rosenwald found great success in his privately owned venture, the Cougar Biotechnology. This company was primarily composed of promising medical experts that are focused on researching for solutions on various types of cancer. After Dr. Rosenwald acquired the license from the initial discoverer of the drug called Abiraterone Acetate, he pompously led his team to make further developments on it.
The Abiraterone Acetate is actually a drug that was known as an effective solution to prostate cancer. One should know that prostate cancer is another deadly disease that is more common in older men. In this disease, the prostate gland – a vital part of the male reproductive organ – has been infected with cancer cells. It often results to various problems with the sufferer’s urination and seminal ejaculation. Tremendous aching of the lower back, hips, and areas surrounding the pelvis is also common. In worst cases, a prostate cancer patient may experience terrible pain during the erection of his penis because of the inflammation in the pelvis. With the help of Abiraterone Acetate and other therapies, the patient can be cured or at least can experience long-term relief from the effects of this disease.
With the rest of Cougar Biotechnology team, Dr. Lindsay Rosenwald successfully demonstrated the effectiveness of the well-developed Abiraterone Acetate in the three phases of clinical trials. It was in 2009 when the results of the Phase II clinical trial were released and captured the attention of Johnson & Johnson. After that, Dr Lindsay Rosenwald accepted the international healthcare company’s offer to acquire the production, marketing, and distribution of Cougar Biotechnology’s very promising product. The acquisition was said to be worth $1 billion.


